Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 12Pain, Postoperative 11Pain 11Breast Neoplasms 9Agnosia 9Depression 8Head and Neck Neoplasms 6Chronic Pain 4Anxiety Disorders 4Pancreatic Neoplasms 3Pain, Intractable 3Colorectal Neoplasms 3Acute Pain 3Prostatic Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Mucositis 2Gastrointestinal Neoplasms 2Cancer Pain 2Stomatitis 1Spinal Stenosis 1Rectal Neoplasms 1Postoperative Analgesia 1Peripheral Nervous System Diseases 1Pelvic Neoplasms 1Pain, Procedural 1Otolaryngeal Cancer 1Neurotoxicity Syndromes 1Lymphoma, Follicular 1Lung Neoplasms 1Laparoscopic Colorectal Resection Due to Cancer 1

Interventions

Radiotherapy 4Paclitaxel 4Carboplatin 4Sodium Chloride 3Oxaliplatin 3Cyclophosphamide 3Vincristine 2Surveys and Questionnaires 2Procarbazine 2Prednisolone 2Methotrexate 2Mental Status and Dementia Tests 2Magnetic Resonance Spectroscopy 2Magnesium Sulfate 2Leucovorin 2Duloxetine Hydrochloride 2Doxorubicin 2Dexamethasone 2Cytarabine 2Calcium Gluconate 2Amifostine 2Acupuncture Therapy 2neurotropin 1motexafin gadolinium 1haloperidol decanoate 1glutamic acid diethyl ester 1glucarpidase 1fludarabine phosphate 1fludarabine 1axicabtagene ciloleucel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neurotoxicity Syndromes × Ketamine × Clear all
NCT00471445 2015-11-09

Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients

University of Rochester

Phase 3 Completed
462 enrolled 14 charts

Pain, Peripheral Nervous System Diseases, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡